| 【Sector Research】China Healthcare - Overseas CXO/ life science upstream 2Q24 review: life science upstream continuing to expect demand recovery |
| 【行业研究】中国医药 - 海外CXO/生命科学上游2Q24业绩剖析：生命科学上游继续预期需求复苏 |
| 【Sector Research】China Insurance - 7M24 Monthly: Life momentum kept strong; P&C edged up by auto & non-auto rebounds |
| 【Sector Research】Property - NBS 7M24: REI decline widened but its components all performed better, why? |
| 【Company Research】CR Beer (291 HK) - 1H24 Rev/NP -0.5%/+1.2%; earnings missed with beer premiumization continues |
| 【Company Research】Yancoal Australia (3668 HK) - 1H24 net profit -57% YoY below expectations; No interim dividend suggests potential M&A |
| 【Company Research】RemeGen (9995 HK) - Strong sales performance in 2Q |
| 【公司研究】贝克微 (2149 HK) - 上半年业绩强劲，保持积极展望 |
| 【Company Research】Li Ning (2331 HK) - We see long-term value but short-term risks |
| 【Company Research】Kingdee (268 HK) - Macro headwinds weighed on growth; loss reduction on track |
公司地址：香港中环花园道三号冠君大厦45-46楼
电话：（852）3900-0888 传真：（852）3761-8788
招银国际版权所有 Copyright © 2019-2026 CMB International Capital Corporation Limited. All rights reserved.
